2024年7月30日 星期二
Phu Quoc Island (富國島)
Phu Quoc Island (富國島)
Phu Quoc Island (富國島) 湯偉晉編寫的英文字典
Phu Quoc Island (富國島) 湯偉晉編寫的英文字典
2024年7月29日 星期一
striated muscle (橫紋肌)
striated muscle (橫紋肌)
striated muscle (橫紋肌) 湯偉晉編寫的英文字典
striated muscle (橫紋肌) 湯偉晉編寫的英文字典
in a military context (在一個軍事運作的情境中)
in a military context (在一個軍事運作的情境中)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
breast abscess (乳腺膿瘍)
breast abscess (乳腺膿瘍)
mastitis (乳腺炎)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
mastitis (乳腺炎)
mastitis (乳腺炎)
breast abscess (乳腺膿瘍)
mastitis (乳腺炎) 湯偉晉編寫的英文字典
mastitis (乳腺炎) 湯偉晉編寫的英文字典
2024年7月28日 星期日
His wife's death reminded him of his own mortality. (他太太的過世讓他想起了他自己的死亡。)
Her husband's death reminded her of her own mortality. (她先生的過世讓她想起了她自己的死亡。)
His wife's death reminded him of his own mortality. (他太太的過世讓他想起了他自己的死亡。)
Her husband's death reminded her of her own mortality. (她先生的過世讓她想起了她自己的死亡。)
Her husband's death reminded her of her own mortality. (她先生的過世讓她想起了她自己的死亡。)
His wife's death reminded him of his own mortality. (他太太的過世讓他想起了他自己的死亡。)
microprocessor (微處理器)
processor (處理器)
microprocessor (微處理器)
microprocessor (微處理器) 湯偉晉編寫的英文字典
microprocessor (微處理器) 湯偉晉編寫的英文字
political strategist (政治戰略家)
political strategist (政治戰略家)
political strategist (政治戰略家) 湯偉晉編寫的英文字典
political strategist (政治戰略家) 湯偉晉編寫的英文字典
I did a lot of thinking over the break. (在休息期間我想了很多。)
I did a lot of thinking over the break. (在休息期間我想了很多。)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
United States Forces Japan (駐日美軍)
United States Forces Japan (駐日美軍)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
That’s my diplomatic response. (那是我的外交式回應。)
That’s my diplomatic response. (那是我的外交式回應。)
That’s my diplomatic response. (那是我的外交式回應。) 湯偉晉編寫的英文字典
That’s my diplomatic response. (那是我的外交式回應。) 湯偉晉編寫的英文字典
He won’t coddle his children. (他不會溺愛他的小孩。)
Placeholder
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
2024年7月27日 星期六
founding document (建國的文件，公司奠基的文件)
founding document (建國的文件，公司奠基的文件)
founding document (建國的文件，公司奠基的文件) 湯偉晉編寫的英文字典
founding document (建國的文件，公司奠基的文件) 湯偉晉編寫的英文字典
the founding document of the United States (美國的建國文件)
the founding document of the United States (美國的建國文件)
the founding document of the United States (美國的建國文件) 湯偉晉編寫的英文字典
the founding document of the United States (美國的建國文件) 湯偉晉編寫的英文字典
Declaration of Independence (獨立宣言)
Declaration of Independence (獨立宣言)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
United States Declaration of Independence (美國的獨立宣言)
United States Declaration of Independence (美國的獨立宣言)
United States Declaration of Independence (美國的獨立宣言) 湯偉晉編寫的英文字典
United States Declaration of Independence (美國的獨立宣言) 湯偉晉編寫的英文字典
candidate (候選人)
political party or candidate (政黨或是候選人)
political party or candidate (政黨或是候選人) 湯偉晉編寫的英文字典
political party or candidate (政黨或是候選人) 湯偉晉編寫的英文字典
political party (政黨)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
Large Language Model (大型語言模型)
Large Language Model (大型語言模型)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
2024年7月26日 星期五
stomatitis (口腔炎)
stomatitis (口腔炎)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
used for flavoring food (用於食物的調味)
used for flavoring food (用於食物的調味)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
proteolysis (蛋白質的水解)
proteolysis (蛋白質的水解)
proteolysis (蛋白質的水解) 湯偉晉編寫的英文字典
proteolysis (蛋白質的水解) 湯偉晉編寫的英文字典
2024年7月25日 星期四
political history (政治的歷史，政治歷史)
political history (政治的歷史，政治歷史)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
in American political history (在美國的政治歷史中)
in American political history (在美國的政治歷史中)
in American political history (在美國的政治歷史中) 湯偉晉編寫的英文字典
in American political history (在美國的政治歷史中) 湯偉晉編寫的英文字典
Jennifer Aniston (珍妮佛．安妮斯頓)
Jennifer Aniston (珍妮佛．安妮斯頓)
Joe Biden (喬．拜登)
Kamala Harris (賀錦麗)
Kamala Harris (卡瑪拉．哈里斯)
Kamala Harris (卡瑪拉．哈利斯)
Kamala Harris (卡瑪拉．哈里斯)，i.e. Kamala Harris (賀錦麗)
Kamala Harris (卡瑪拉．哈里斯)，i.e. Kamala Harris (賀錦麗)
Jennifer Aniston (珍妮佛．安妮斯頓) 湯偉晉編寫的英文字典
Jennifer Aniston (珍妮佛．安妮斯頓) 聲援 Kamala Harris (卡瑪拉．哈里斯)，i.e. Kamala Harris (賀錦麗)
Jennifer Aniston (珍妮佛．安妮斯頓) 湯偉晉編寫的英文字典
2024年7月23日 星期二
clot retraction test (血塊收縮試驗)
clot retraction test (血塊收縮試驗)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
2024年7月22日 星期一
Claire (克蕾兒)
Claire (克蕾兒)
Claire (克萊爾)
Claire (克雷兒，克萊爾)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
Claire (克雷兒，克萊爾)
Claire (克雷兒)
Claire (克萊爾)
Claire (克雷兒，克萊爾)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
Defense Language Institute (國防語言學院)
Defense Language Institute (國防語言學院)
Defense Language Institute (國防語言學院) 湯偉晉編寫的英文字典
Defense Language Institute (國防語言學院) 湯偉晉編寫的英文字典
Kamala Harris (卡瑪拉．哈里斯)
Joe Biden (喬．拜登)
Kamala Harris (賀錦麗)
Kamala Harris (卡瑪拉．哈里斯)
Kamala Harris (卡瑪拉．哈利斯)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
finish line (終點線)
finish line (終點線)
She crossed the finish line (她衝過了終點線)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
She crossed the finish line (她衝過了終點線)
She crossed the finish line (她衝過了終點線)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
He crossed the finish line (他衝過了終點線)
He crossed the finish line (他衝過了終點線)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
Princess Diana (戴安娜王妃)
Princess Diana (戴安娜王妃)
Princess Diana (戴安娜王妃)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
President Biden (拜登總統)
President Biden (拜登總統)
Joe Biden (喬．拜登)
President Biden (拜登總統) 湯偉晉編寫的英文字典
President Biden (拜登總統) 湯偉晉編寫的英文字典
2024年7月21日 星期日
beat Trump (擊敗川普)
beat Trump (擊敗川普)
Democrats -- it's time to come together and beat Trump. Let's do this.
vapor density (蒸氣密度)
vapor density: the density of a particular gas or vapor relative to that of hydrogen at the same pressure and temperature. (蒸氣密度：在相同壓力和溫度下特定氣體或蒸氣相對於氫氣的密度。)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
scramble (緊急升空)
Air Force fighter jets scrambled to intercept enemy aircraft (空軍的戰鬥機緊急升空去攔截敵人的飛機)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
scrambled (緊急升空)
Air Force fighter jets scrambled to intercept enemy aircraft (空軍的戰鬥機緊急升空去攔截敵人的飛機)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
Russian jet (俄羅斯的戰鬥機)
Russian jet (俄羅斯的戰鬥機)
Russian jets (俄羅斯的戰鬥機)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
disgraced former white house physician (名譽掃地的前白宮醫師)
disgraced former white house physician (名譽掃地的前白宮醫師)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
For all the attention (儘管備受關注)
For all the attention, surprisingly little information about Trump's post-shooting health. (儘管備受關注，但是有關於川普在槍擊後的健康狀態的資訊卻少得令人驚訝。)
2024年7月20日 星期六
The Battle for American Democracy (一場為美國的民主而戰的戰爭)
The Battle for American Democracy (一場為美國的民主而戰的戰爭)
The Battle for American Democracy (一場為美國的民主而戰的戰爭) 湯偉晉編寫的英文字典
The Battle for American Democracy (一場為美國的民主而戰的戰爭) 湯偉晉編寫的英文字典
Holding hands together in joy and sorrow (在歡樂與悲傷的時刻，一起手牽著手)
Holding hands together in joy and sorrow (在歡樂與悲傷的時刻，一起手牽著手)
Holding hands together in joy and sorrow (在歡樂與悲傷的時刻，一起手牽著手) 湯偉晉編寫的英文字典
2024年7月19日 星期五
Dermatan Sulfate (硫酸皮膚素)
Dermatan Sulfate (硫酸皮膚素)
chondroitin sulfate
硫酸軟骨素
chondroitin sulfate (硫酸軟骨素)
硫酸軟骨素 (chondroitin sulfate)
chondroitin sulfate sodium
硫酸軟骨素鈉
chondroitin sulfate sodium (硫酸軟骨素鈉)
硫酸軟骨素鈉 (chondroitin sulfate sodium )
Keratan Sulfate (硫酸角質素，角質素硫酸鹽)
Dermatan Sulfate (硫酸皮膚素)
chondroitin sulfate
硫酸軟骨素
chondroitin sulfate (硫酸軟骨素)
硫酸軟骨素 (chondroitin sulfate)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
peptide bond (胜肽鍵)
peptide (胜肽)
peptide bond (胜肽鍵) peptide bond (胜肽鍵) 湯偉晉編寫的英文字典
peptide bond (胜肽鍵) 湯偉晉編寫的英文字典
2024年7月18日 星期四
kainic acid (紅藻胺酸)
kainic acid (紅藻胺酸)
kainic acid (紅藻胺酸，海人酸)
kainic acid (紅藻胺酸，海人酸)
kainic acid (紅藻胺酸，海人酸) 湯偉晉編寫的英文字典
kainic acid (紅藻胺酸，海人酸) 湯偉晉編寫的英文字典
kainic acid (紅藻胺酸，海人酸)
kainic acid (紅藻胺酸，海人酸)
kainic acid (紅藻胺酸，海人酸) 湯偉晉編寫的英文字典
kainic acid (紅藻胺酸，海人酸) 湯偉晉編寫的英文字典
Taiwan Pediatric Association (臺灣兒科醫學會)
Taiwan Pediatric Association (臺灣兒科醫學會)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
sudden infant death syndrome (嬰兒猝死症)
sudden infant death syndrome (嬰兒猝死症候群，嬰兒猝死症)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
sudden infant death syndrome (嬰兒猝死症候群，嬰兒猝死症)
Placeholder
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
sudden infant death syndrome (嬰兒猝死症候群)
sudden infant death syndrome (嬰兒猝死症候群)
IT industry (資訊產業)
information technology (資訊科技)
IT industry (資訊產業)
Placeholder 湯偉晉編寫的英文字典
Placeholder 湯偉晉編寫的英文字典
law dictionary (法律詞典，法律字典)
legal dictionary (法律詞典，法律字典), law dictionary (法律詞典，法律字典)
2024年7月17日 星期三
Professor Cheng-Feng Shih (施正鋒 教授)
Professor Cheng-Feng Shih (施正鋒 教授)
Cheng-Feng Shih (施正鋒)
Cheng-Feng Shih (施正鋒)
Professor Cheng-Feng Shih (施正鋒 教授)
2024年7月15日 星期一
Electron Paramagnetic Resonance (EPR)-spin trapping technique
Placeholder
Placeholder 湯偉晉編寫的英文字典
Methods
Samples of both healthy thyroid tissue and thyroid tumor were taken for analysis after total thyroidectomy. The expression of GPx1 and TrxR1 was revealed by Western blot analysis and quantified by densitometric analyses, while the evaluation of free radicals was performed by Electron Paramagnetic Resonance (EPR)-spin trapping technique.
#
A possible role for selenoprotein glutathione peroxidase (GPx1) and thioredoxin reductases (TrxR1) in thyroid cancer: our experience in thyroid surgery
Source or References (資訊來源或是參考的資訊):
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769232/
Info cited on 2024-07-16-WD2 (資訊引用於 中華民國113年西元2024年7月16日) by 湯偉晉 (WeiJin Tang)
#
Placeholder 湯偉晉編寫的英文字典
similar article (類似的文章)
similar article
類似的文章
similar article (類似的文章)
類似的文章 (similar article)
See all similar articles
看所有類似的文章
See all similar articles (看所有類似的文章)
看所有類似的文章 (See all similar articles)
See all similar articles (看所有類似的文章)
similar article
類似的文章
similar article (類似的文章)
類似的文章 (similar article)
See all similar articles
看所有類似的文章
See all similar articles (看所有類似的文章)
看所有類似的文章 (See all similar articles)
clinical stage (臨床階段)
Analysis of the diagnostic efficiency of serum oxidative stress parameters in patients with breast cancer at various clinical stages.
血清氧化壓力參數對不同臨床階段乳癌患者的診斷效能分析
at various clinical stages
在各種不同的臨床階段
at various clinical stages (在各種不同的臨床階段)
在各種不同的臨床階段 (at various clinical stages)
clinical stage
臨床階段
clinical stage (臨床階段)
臨床階段 (clinical stage)
clinical stages
臨床階段
clinical stages (臨床階段)
臨床階段 (clinical stages)
at various clinical stages (在各種不同的臨床階段)
at
various clinical stages
在各種不同的臨床階段
at various clinical stages (在各種不同的臨床階段)
在各種不同的臨床階段 (at various clinical stages)
clinical stage
臨床階段
clinical stage (臨床階段)
臨床階段 (clinical stage)
clinical stages
臨床階段
clinical stages (臨床階段)
臨床階段 (clinical stages)
在各種不同的臨床階段
at various clinical stages (在各種不同的臨床階段)
在各種不同的臨床階段 (at various clinical stages)
clinical stage
臨床階段
clinical stage (臨床階段)
臨床階段 (clinical stage)
clinical stages
臨床階段
clinical stages (臨床階段)
臨床階段 (clinical stages)
Total oxidant/antioxidant status in sera of patients with thyroid cancers (在 甲狀腺癌患者 的 血清中 總 氧化劑/抗氧化劑 的狀態)
Total
oxidant/antioxidant status in sera of patients with thyroid cancers
在 甲狀腺癌患者 的 血清中 總 氧化劑/抗氧化劑 的狀態
Total oxidant/antioxidant status in sera of patients with thyroid cancers (在 甲狀腺癌患者 的 血清中 總 氧化劑/抗氧化劑 的狀態)
在 甲狀腺癌患者 的 血清中 總 氧化劑/抗氧化劑 的狀態 (Total oxidant/antioxidant status in sera of patients with thyroid cancers)
在 甲狀腺癌患者 的 血清中 總 氧化劑/抗氧化劑 的狀態
Total oxidant/antioxidant status in sera of patients with thyroid cancers (在 甲狀腺癌患者 的 血清中 總 氧化劑/抗氧化劑 的狀態)
在 甲狀腺癌患者 的 血清中 總 氧化劑/抗氧化劑 的狀態 (Total oxidant/antioxidant status in sera of patients with thyroid cancers)
Placeholder 湯偉晉編寫的英文字典
--- - - --- - - ---
2024-07-16
Total oxidant/antioxidant status in sera of patients with thyroid cancers
在 甲狀腺癌患者 的 血清中 總 氧化劑/抗氧化劑 的狀態
Source or References (資訊來源或是參考的資訊):
https://pubmed.ncbi.nlm.nih.gov/22002574/
Info cited on 2024-07-16-WD2 (資訊引用於 中華民國113年西元2024年7月16日) by 湯偉晉 (WeiJin Tang)
#
- - - - - - - -
Endocr Relat Cancer
2011 Dec 1;18(6):773-82. doi: 10.1530/ERC-11-0230. Print 2011 Dec.
Total oxidant/antioxidant status in sera of patients with thyroid cancers
Dong Wang 1, Jia-Fu Feng, Ping Zeng, Yun-Hong Yang, Jun Luo, Yu-Wei Yang
Affiliation
1Department of Oncology, Mianyang Central Hospital, Mianyang, Sichuan Province, China.
PMID: 22002574 PMCID: PMC3230112 DOI: 10.1530/ERC-11-0230
Abstract
Oxidative stress is considered to be involved in the pathophysiology of all cancers. In order to evaluate the total oxidant/antioxidant status in patients with thyroid cancer and to investigate the relationship between oxidative stress parameters and serum thyroid profiles among thyroid cancer patients and various controls, we determined oxidative status including total antioxidant status (TAS) and total oxidant status (TOS) and calculation of oxidative stress index (OSI) in sera in 82 thyroid cancer patients, 56 benign thyroid disease patients, and 50 healthy controls. It was found that serum TAS levels were significantly lower in patients with thyroid cancer than in controls (P<0.001), while serum TOS levels and OSI values were significantly higher (both P<0.001) in the cancer patients. No significant correlations were observed between various oxidative stress markers and thyroid profiles in either the thyroid cancer patients or the controls. Receiver operating characteristic curve analysis demonstrated that OSI was the best indicator for distinguishing cancer patients from benign thyroid diseased or healthy controls, followed by TOS and TAS. Risk estimate statistics also indicated that TOS and/or OSI were good risk factors to discriminate patients with thyroid cancer from two controls. These findings suggested that oxidants are increased and antioxidants are decreased in patients with thyroid cancer. OSI may be a more useful oxidative stress biomarker than TAS and TOS for monitoring the clinical status of thyroid cancer patients.
Begin_電腦自動翻譯的內容_Y2024M07D16H03M17Rn6827_
(請注意：電腦自動翻譯的內容，可能會夾雜一些錯誤！)
氧化壓力被認為與所有癌症的病理生理學有關。為了評估甲狀腺癌患者的總氧化/抗氧化狀態，並探討甲狀腺癌患者和不同對照者氧化壓力參數與血清甲狀腺光譜之間的關係，我們測定了氧化狀態，包括總氧化狀態（TAS）和總氧化程度。結果發現，甲狀腺癌患者血清TAS水準顯著低於對照組（P<0.001），而癌症患者血清TOS水準和OSI值顯著上升（均P<0.001）。在甲狀腺癌患者或對照組中，各種氧化壓力標記與甲狀腺特徵之間沒有觀察到顯著相關性。受試者工作特徵曲線分析表明，OSI 是區分癌症患者與良性甲狀腺疾病或健康對照組的最佳指標，其次是 TOS 和 TAS。風險估計統計數據還表明，TOS 和/或 OSI 是區分甲狀腺癌患者與兩名對照患者的良好風險因素。這些發現表明，甲狀腺癌患者體內的氧化劑增加，抗氧化劑減少。 OSI 可能是比 TAS 和 TOS 更有用的氧化壓力生物標記物，用於監測甲狀腺癌患者的臨床狀態。
End_電腦自動翻譯的內容_Y2024M07D16H03M17Rn6827_
Comment in
Oxidative stress: a new risk factor for thyroid cancer.
Xing M.
PMID: 22143496
Similar articles
Sera total oxidant/antioxidant status in lung cancer patients.
Xiang M, Feng J, Geng L, Yang Y, Dai C, Li J, Liao Y, Wang D, Du XB.
Medicine (Baltimore). 2019 Sep
PMID: 31517874
Total Oxidant/Antioxidant Status in Sera of Patients with Esophageal Cancer.
Huang Q, Feng J, Wu R, Yang Y, Dai C, Li J, Liao Y, Xiang M, Wang D, Du XB.
Med Sci Monit. 2017 Aug 4
PMID: 28777781
Papillary Thyroid Carcinoma: A Malignant Tumor with Increased Antioxidant Defense Capacity.
Rovcanin BR, Gopcevic KR, Kekic DLj, Zivaljevic VR, Diklic ADj, Paunovic IR.
Tohoku J Exp Med. 2016 Oct
PMID: 27615359
Analysis of the diagnostic efficiency of serum oxidative stress parameters in patients with breast cancer at various clinical stages.
Feng JF, Lu L, Dai CM, Wang D, Yang YH, Yang YW, Liu YS.
Clin Biochem. 2016 Jun
PMID: 26899366
Evaluation of total oxidant and antioxidant status in localized and generalized vitiligo.
Akoglu G, Emre S, Metin A, Akbas A, Yorulmaz A, Isikoglu S, Sener S, Kilinc F.
Clin Exp Dermatol. 2013 Oct
PMID: 23601201
Cited by
Monitoring Metastatic Colorectal Cancer Progression According to Reactive Oxygen Metabolite Derivative Levels.
Sawai K, Goi T, Kimura Y, Koneri K.
Cancers (Basel). 2023 Nov 22
PMID: 38067221
Analysis of redox status and HDL subclasses in patients with lymphoma and the associations with FDG-PET/CT findings.
Mirjanic-Azaric B, Stankovic S, Nezic L, Radic Savic Z, Malcic-Zanic D, Skrbic R, Kotur-Stevuljevic J, Bogavac-Stanojevic N.
Front Oncol. 2023 Oct 30
PMID: 37965473
Influence of the circadian cycle, sex and production stage on the reference values of parameters related to stress and pathology in porcine saliva.
Saco Y, Peña R, Matas-Quintanilla M, Ibáñez-López FJ, Piñeiro M, Sotillo J, Bassols A, Gutiérrez AM.
Porcine Health Manag. 2023 Sep 29;9(1):42. doi: 10.1186/s40813-023-00337-7.
PMID: 37773175
MiR-146b-5p regulates the scavenging effect of GPx-3 on peroxide in papillary thyroid cancer cells.
Zhang D, Deng JJ, Xu Q, Zeng Y, Jiang J.
Heliyon. 2023 Jul 20;9(8):e18489. doi: 10.1016/j.heliyon.2023.e18489. eCollection 2023 Aug.
PMID: 37533981
Could Oxidative Stress Play a Role in the Development and Clinical Management of Differentiated Thyroid Cancer?
Kościuszko M, Buczyńska A, Krętowski AJ, Popławska-Kita A.
Cancers (Basel). 2023 Jun 14;15(12):3182. doi: 10.3390/cancers15123182.
PMID: 37370792 Review.
See all "Cited by" articles
References
Abiaka C, Al-Awadi F, Al-Sayer H, Gulshan S, Behbehani A, Farghally M, Simbeye A. Serum antioxidant and cholesterol levels in patients with different types of cancer. Journal of Clinical Laboratory Analysis. 2001;15:324–330. doi: 10.1002/jcla.1045. - DOI - PMC - PubMed
Akinci M, Kosova F, Cetin B, Sepici A, Altan N, Aslan S, Cetin A. Oxidant/antioxidant balance in patients with thyroid cancer. Acta Cirúrgica Brasileira. 2008;23:551–554. doi: 10.1590/S0102-86502008000600013. - DOI - PubMed
Alkhenizan A, Hafez K. The role of vitamin E in the prevention of cancer: a meta-analysis of randomized controlled trials. Annals of Saudi Medicine. 2007;27:409–414. doi: 10.4103/0256-4947.51459. - DOI - PMC - PubMed
Andryskowski G, Owczarek T. The evaluation of selected oxidative stress parameters in patients with hyperthyroidism. Polskie Archiwum Medycyny Wewnetrznej. 2007;117:285–289. - PubMed
Aslan M, Cosar N, Celik H, Aksoy N, Dulger AC, Begenik H, Soyoral YU, Kucukoglu ME, Selek S. Evaluation of oxidative status in patients with hyperthyroidism. Endocrine. 2011;40:285–289. doi: 10.1007/s12020-011-9472-3. - DOI - PubMed
- - - - -- -- - -
--- --- - - --- ---
2024-07-16
Total oxidant/antioxidant status in sera of patients with thyroid cancers
在 甲狀腺癌患者 的 血清中 總 氧化劑/抗氧化劑 的狀態
Source or References (資訊來源或是參考的資訊):
https://pubmed.ncbi.nlm.nih.gov/22002574/
Info cited on 2024-07-16-WD2 (資訊引用於 中華民國113年西元2024年7月16日) by 湯偉晉 (WeiJin Tang)
#
- - - - - - - -
Endocr Relat Cancer
2011 Dec 1;18(6):773-82. doi: 10.1530/ERC-11-0230. Print 2011 Dec.
Total oxidant/antioxidant status in sera of patients with thyroid cancers
Dong Wang 1, Jia-Fu Feng, Ping Zeng, Yun-Hong Yang, Jun Luo, Yu-Wei Yang
Affiliation
1Department of Oncology, Mianyang Central Hospital, Mianyang, Sichuan Province, China.
PMID: 22002574 PMCID: PMC3230112 DOI: 10.1530/ERC-11-0230
Abstract
Oxidative stress is considered to be involved in the pathophysiology of all cancers. In order to evaluate the total oxidant/antioxidant status in patients with thyroid cancer and to investigate the relationship between oxidative stress parameters and serum thyroid profiles among thyroid cancer patients and various controls, we determined oxidative status including total antioxidant status (TAS) and total oxidant status (TOS) and calculation of oxidative stress index (OSI) in sera in 82 thyroid cancer patients, 56 benign thyroid disease patients, and 50 healthy controls. It was found that serum TAS levels were significantly lower in patients with thyroid cancer than in controls (P<0.001), while serum TOS levels and OSI values were significantly higher (both P<0.001) in the cancer patients. No significant correlations were observed between various oxidative stress markers and thyroid profiles in either the thyroid cancer patients or the controls. Receiver operating characteristic curve analysis demonstrated that OSI was the best indicator for distinguishing cancer patients from benign thyroid diseased or healthy controls, followed by TOS and TAS. Risk estimate statistics also indicated that TOS and/or OSI were good risk factors to discriminate patients with thyroid cancer from two controls. These findings suggested that oxidants are increased and antioxidants are decreased in patients with thyroid cancer. OSI may be a more useful oxidative stress biomarker than TAS and TOS for monitoring the clinical status of thyroid cancer patients.
Begin_電腦自動翻譯的內容_Y2024M07D16H03M17Rn6827_
(請注意：電腦自動翻譯的內容，可能會夾雜一些錯誤！)
氧化壓力被認為與所有癌症的病理生理學有關。為了評估甲狀腺癌患者的總氧化/抗氧化狀態，並探討甲狀腺癌患者和不同對照者氧化壓力參數與血清甲狀腺光譜之間的關係，我們測定了氧化狀態，包括總氧化狀態（TAS）和總氧化程度。結果發現，甲狀腺癌患者血清TAS水準顯著低於對照組（P<0.001），而癌症患者血清TOS水準和OSI值顯著上升（均P<0.001）。在甲狀腺癌患者或對照組中，各種氧化壓力標記與甲狀腺特徵之間沒有觀察到顯著相關性。受試者工作特徵曲線分析表明，OSI 是區分癌症患者與良性甲狀腺疾病或健康對照組的最佳指標，其次是 TOS 和 TAS。風險估計統計數據還表明，TOS 和/或 OSI 是區分甲狀腺癌患者與兩名對照患者的良好風險因素。這些發現表明，甲狀腺癌患者體內的氧化劑增加，抗氧化劑減少。 OSI 可能是比 TAS 和 TOS 更有用的氧化壓力生物標記物，用於監測甲狀腺癌患者的臨床狀態。
End_電腦自動翻譯的內容_Y2024M07D16H03M17Rn6827_
Comment in
Oxidative stress: a new risk factor for thyroid cancer.
Xing M.
PMID: 22143496
Similar articles
Sera total oxidant/antioxidant status in lung cancer patients.
Xiang M, Feng J, Geng L, Yang Y, Dai C, Li J, Liao Y, Wang D, Du XB.
Medicine (Baltimore). 2019 Sep
PMID: 31517874
Total Oxidant/Antioxidant Status in Sera of Patients with Esophageal Cancer.
Huang Q, Feng J, Wu R, Yang Y, Dai C, Li J, Liao Y, Xiang M, Wang D, Du XB.
Med Sci Monit. 2017 Aug 4
PMID: 28777781
Papillary Thyroid Carcinoma: A Malignant Tumor with Increased Antioxidant Defense Capacity.
Rovcanin BR, Gopcevic KR, Kekic DLj, Zivaljevic VR, Diklic ADj, Paunovic IR.
Tohoku J Exp Med. 2016 Oct
PMID: 27615359
Analysis of the diagnostic efficiency of serum oxidative stress parameters in patients with breast cancer at various clinical stages.
Feng JF, Lu L, Dai CM, Wang D, Yang YH, Yang YW, Liu YS.
Clin Biochem. 2016 Jun
PMID: 26899366
Evaluation of total oxidant and antioxidant status in localized and generalized vitiligo.
Akoglu G, Emre S, Metin A, Akbas A, Yorulmaz A, Isikoglu S, Sener S, Kilinc F.
Clin Exp Dermatol. 2013 Oct
PMID: 23601201
Cited by
Monitoring Metastatic Colorectal Cancer Progression According to Reactive Oxygen Metabolite Derivative Levels.
Sawai K, Goi T, Kimura Y, Koneri K.
Cancers (Basel). 2023 Nov 22
PMID: 38067221
Analysis of redox status and HDL subclasses in patients with lymphoma and the associations with FDG-PET/CT findings.
Mirjanic-Azaric B, Stankovic S, Nezic L, Radic Savic Z, Malcic-Zanic D, Skrbic R, Kotur-Stevuljevic J, Bogavac-Stanojevic N.
Front Oncol. 2023 Oct 30
PMID: 37965473
Influence of the circadian cycle, sex and production stage on the reference values of parameters related to stress and pathology in porcine saliva.
Saco Y, Peña R, Matas-Quintanilla M, Ibáñez-López FJ, Piñeiro M, Sotillo J, Bassols A, Gutiérrez AM.
Porcine Health Manag. 2023 Sep 29;9(1):42. doi: 10.1186/s40813-023-00337-7.
PMID: 37773175
MiR-146b-5p regulates the scavenging effect of GPx-3 on peroxide in papillary thyroid cancer cells.
Zhang D, Deng JJ, Xu Q, Zeng Y, Jiang J.
Heliyon. 2023 Jul 20;9(8):e18489. doi: 10.1016/j.heliyon.2023.e18489. eCollection 2023 Aug.
PMID: 37533981
Could Oxidative Stress Play a Role in the Development and Clinical Management of Differentiated Thyroid Cancer?
Kościuszko M, Buczyńska A, Krętowski AJ, Popławska-Kita A.
Cancers (Basel). 2023 Jun 14;15(12):3182. doi: 10.3390/cancers15123182.
PMID: 37370792 Review.
See all "Cited by" articles
References
Abiaka C, Al-Awadi F, Al-Sayer H, Gulshan S, Behbehani A, Farghally M, Simbeye A. Serum antioxidant and cholesterol levels in patients with different types of cancer. Journal of Clinical Laboratory Analysis. 2001;15:324–330. doi: 10.1002/jcla.1045. - DOI - PMC - PubMed
Akinci M, Kosova F, Cetin B, Sepici A, Altan N, Aslan S, Cetin A. Oxidant/antioxidant balance in patients with thyroid cancer. Acta Cirúrgica Brasileira. 2008;23:551–554. doi: 10.1590/S0102-86502008000600013. - DOI - PubMed
Alkhenizan A, Hafez K. The role of vitamin E in the prevention of cancer: a meta-analysis of randomized controlled trials. Annals of Saudi Medicine. 2007;27:409–414. doi: 10.4103/0256-4947.51459. - DOI - PMC - PubMed
Andryskowski G, Owczarek T. The evaluation of selected oxidative stress parameters in patients with hyperthyroidism. Polskie Archiwum Medycyny Wewnetrznej. 2007;117:285–289. - PubMed
Aslan M, Cosar N, Celik H, Aksoy N, Dulger AC, Begenik H, Soyoral YU, Kucukoglu ME, Selek S. Evaluation of oxidative status in patients with hyperthyroidism. Endocrine. 2011;40:285–289. doi: 10.1007/s12020-011-9472-3. - DOI - PubMed
- - - - -- -- - -
--- --- - - --- ---
Placeholder 湯偉晉編寫的英文字典
訂閱：
文章 (Atom)
